Larry L. Wood - 11 Oct 2022 Form 4 Insider Report for Edwards Lifesciences Corp (EW)

Role
CVP, TAVR
Signature
Linda J. Park, Attorney-in-Fact
Issuer symbol
EW
Transactions as of
11 Oct 2022
Net transactions value
-$328,570
Form type
4
Filing time
11 Oct 2022, 18:22:25 UTC
Previous filing
06 Sep 2022
Next filing
08 Nov 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction EW Common Stock Options Exercise $266,144 +7,242 +3.6% $36.75 209,474 11 Oct 2022 Direct F1
transaction EW Common Stock Sale $594,713 -7,242 -3.5% $82.12 202,232 11 Oct 2022 Direct F1
holding EW Common Stock 496 11 Oct 2022 401(k)

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction EW Employee Stock Option (Right to Acquire) Options Exercise $0 -7,242 -33% $0.000000 14,478 11 Oct 2022 Common Stock 7,242 $36.75 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 24, 2021.

Remarks:

This Form 4 reflects changes in beneficial ownership only; it does not identify other securities of the Issuer beneficially owned by the Reporting Person.